ODI Pharma AB
STO: ODI.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jan-Mark Edewaard
- Employees
- 1
- Headquarters
- Stockholm, Sweden
- IPO year
- 2020
- Market cap
- SEK 68.2M
- Website
- https://www.odipharma.com
Loading ODI…
Loading profile data…Frequently asked questions about ODI
What does ODI Pharma AB (ODI.ST) do?
ODI Pharma AB (publ), a pharmaceutical company, produces and distributes pharmaceutical cannabis and cosmetics products in Europe. The company offers cannabidiol-infused facial cream, facial mask, and body balm under the Kandol. brand name through kandol.net. The company was founded in 2018 and is based in Stockholm, Sweden.
Where does ODI.ST trade?
ODI Pharma AB (ODI.ST) trades on the Stockholm Stock Exchange.
What sector is ODI.ST in?
ODI Pharma AB (ODI.ST) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of ODI Pharma AB?
Jan-Mark Edewaard is the chief executive officer of ODI Pharma AB (ODI.ST).
Where is ODI Pharma AB headquartered?
ODI Pharma AB is headquartered in Sweden.
Does ODI.ST pay a dividend?
ODI Pharma AB (ODI.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ODI.ST go public?
ODI Pharma AB (ODI.ST) completed its initial public offering in 2020.